Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall bextraBextra dosage is determined by the type of pain treated and specific patient information. Bextra was approved by the FDA in November 2001 to treat the pain associated with osteoarthritis, rheumatoid arthritis, and primary dysmenorrhea (severe menstrual cramps). The recommended daily Bextra dosage for arthritis is ten milligrams taken orally once a day. The recommended Bextra dosage for treatment of severe menstrual cramps is twenty milligrams twice daily as needed.
The proper Bextra dosage for a patient is dependent upon their medical history and current medications, as these factors can greatly influence the action of a Bextra dosage in the body. There are several things that a patient will wish to discuss with their doctor before a Bextra dosage is established.
Patients should tell their practitioner if they have experienced an allergic reaction to sulfonamide drugs or drugs that are similar to Bextra (other non-steroidal anti-inflammatory pain medications). Patients with a history of liver, kidney, or heart problems and people who plan to receive surgery while taking Bextra should also discuss these health issues with their doctor when determining whether Bextra will be more beneficial than the potential risks associated with this medication in light of your medical specifics.
There are also a number of medications that interact with any Bextra dosage, so it is important to tell your doctor all recent and current medications and supplements you are taking, prior to deciding what Bextra dosage is right for you, or whether or not you would benefit from Bextra treatment. The following medications can interact with a Bextra dosage: warfarin, aspirin, oral contraceptives, anticonvulsants, ACE-Inhibitors, valium, lithium, and several others.
There are also a number of common as well as serious side effects that are associated with Bextra. The common side effects of a Bextra dosage can include: abdominal pain, headache, nausea, indigestion, and diarrhea. The more serious side effects associated with Bextra dosage administration may include anaphylactic and allergic reactions to a Bextra dosage and serious skin problems.
Particularly during the first two weeks of Bextra dosage administration, patients are at risk for developing serious skin conditions that are caused by this medication. In more serious cases, Bextra use can cause Stevens-Johnson syndrome and toxic epidermal necrolysis. Itchy skin, rash, or any other adverse skin problems should be examined by a medical professional as soon as they develop.
There are also concerns regarding the effects of Bextra dosage on cardiovascular and cerebrovascular health. In some cases, particularly after surgery, patients may be at an increased risk of suffering stroke or heart problems as a result of Bextra use. If you have concerns about Bextra dosage, you should speak with your doctor at your earliest convenience.
Bextra , the popular cox-2 inhibitor recalled by Pfizer, is the subject of another lawsuit.
Rita Fohne has filed her lawsuit against Pfizer in Madison County, Illinois, seeking ...
The U.S. Food and Drug Administration has started issuing alerts to patients and doctors on its new site Drug Watch. Including emerging drug-safety concerns, as well as dangers presented by drugs prescribed for unapproved uses, the new site is in resp...
After a controversial year of drug recalls, the FDA was under attack for failing to adequately protect consumers from dangerous drugs. Currently, the FDA has the Adverse Event Reporting System, or AERS, to collect voluntary reports of possible reactio...